Temocillin vs Meropenem for the Targeted Treatment of Bacteraemia Resistant to Third Gen Cephalosporins

NCT04478721 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

334

Enrollment

OTHER

Sponsor class

Conditions

Bacteremia

Interventions

DRUG: Temocillin
DRUG: Meropenem

Sponsor

Fundación Pública Andaluza para la gestión de la Investigación en Sevilla

Collaborators

[object Object]
[object Object]